Alpine Associates Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NGD
New Gold Inc
NGD
|
+$70.5M |
| 2 |
AL
Air Lease Corp
AL
|
+$68.4M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$64.7M |
| 4 |
Boeing
BA
|
+$60.6M |
| 5 |
RNAM
Avidity Biosciences
RNAM
|
+$56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$123M |
| 2 |
K
Kellanova
K
|
+$108M |
| 3 |
SPR
Spirit AeroSystems
SPR
|
+$102M |
| 4 |
COOP
Mr. Cooper
COOP
|
+$86.6M |
| 5 |
MRUS
Merus
MRUS
|
+$78.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 25.91% |
| 2 | Healthcare | 18.41% |
| 3 | Technology | 16.19% |
| 4 | Communication Services | 14.01% |
| 5 | Financials | 7.86% |
Similar funds
Alpine Associates Management's Q4 2025 Portfolio in Review
As of Q4 2025, Alpine Associates Management held 107 positions worth $1.5B, down 9.3% from $1.66B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Alpine Associates Management withdrew a net $217M in Q4 2025, closing 40 positions and reducing 14 holdings. Its most notable exit was Verona Pharma, an estimated $123M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Alpine Associates Management opened a new position in New Gold Inc worth $81.6M.
- Alpine Associates Management's largest Q4 2025 buy was New Gold Inc: 9,363,161 shares worth $81.6M.
- Alpine Associates Management added most to Air Lease Corp in Q4 2025, an estimated $68.4M increase.
- Alpine Associates Management's biggest Q4 2025 reduction was Chart Industries, cutting an estimated $15.8M.
- Alpine Associates Management fully exited Verona Pharma in Q4 2025, selling an estimated $123M.
- Alpine Associates Management's ten largest holdings make up 53% of its $1.5B portfolio in Q4 2025.
- Alpine Associates Management opened 40 new positions and closed 40 in Q4 2025.
- Alpine Associates Management's portfolio value fell 9.3% quarter-over-quarter to $1.5B.
Based on Alpine Associates Management's 13F filing for Q4 2025, filed 5 Feb 2026.